003220 — Daewon Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Market Cap
KR₩220bn
Enterprise Value
KR₩358bn
Revenue
KR₩605bn

Annual balance sheet for Daewon Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	54,820	47,006	30,030	46,108	75,875
Net Total Accounts Receivable
Net Total Receivables	54,595	66,847	73,387	77,929	80,374
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	180,377	207,284	209,293	257,570	256,603
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	166,674	158,912	160,092	208,378	222,902
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	429,580	453,550	507,998	583,389	613,651
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	102,076	128,146	182,690	200,776	216,337
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	210,281	202,603	241,799	308,104	347,733
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	219,299	250,947	266,199	275,285	265,918
Total Liabilities & Shareholders' Equity	429,580	453,550	507,998	583,389	613,651
Total Common Shares Outstanding